Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management

Exploring precision therapeutics: computational design of antisense oligonucleotides targeting AXL gene transcripts in multiple sclerosis treatment management

Multiple sclerosis (MS) is a chronic autoimmune illness characterized by demyelination, neurodegeneration, and inflammation in the central nervous system. The AXL gene, which codes for a receptor tyrosine kinase, has emerged as a promising therapeutic target due to its involvement in neuroinflammati...

Description complète

Détails bibliographiques
Auteurs principaux: Bhargav Shreevatsa, Abhigna Nagaraj, Chandan Dharmashekar, Anisha Jain, Bhavana Harendra, Siddesh V. Siddalingegowda, Haneen A. Al-Mazroua, Sheikh F. Ahmad, Shashanka K. Prasad, Chandrashekar Srinivasa, Chandan Shivamallu, Shiva Prasad Kollur
Format: Article
Langue:English
Publié: Frontiers Media S.A. 2025-02-01
Collection:Frontiers in Chemistry
Sujets:
AXL gene
antisense oligonucleotides
multiple sclerosis
neurodegeneration inflammation
therapeutics
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fchem.2025.1548269/full

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2025.1548269/full

Documents similaires